Not a jokePaul building a bigger and stronger company, what a misleading statement ! For those who don't know, the market knows better what THTX is all about: a failing company that has the most efficient HIV drug and has been, up to now, incapable to sell it worldwide.
Then, like magiciens, they come up with a NASH program and a technology that supposedly makes a difference in the cancer treatement approach. They completely ignore their failure in Trogarzo and Egrifta: no plan to boost sales. In 2 years from now, they will find something else to buy time and bye bye Nash program and Cancer pipeline.